Loading clinical trials...
Loading clinical trials...
Early Exploratory Clinical Study on the Safety, Tolerability and Preliminary Efficacy of JY231 Injection in the Treatment of Acute B Lymphoblastic Leukemia
Conditions
Interventions
JY231
Locations
1
China
920th HJointLogistics
Kunming, Yunnan, China
Start Date
June 20, 2024
Primary Completion Date
June 30, 2026
Completion Date
June 30, 2026
Last Updated
January 6, 2026
NCT05397496
NCT04166838
Lead Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions